Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Delays in fast track antiretroviral therapy initiation and reasons for not starting treatment among eligible children in Eastern Cape, South Africa

Teasdale, Chloe A.a,b; Yuengling, Katharine A.a; Mutiti, Anthonya; Arpadi, Stephena,b; Nxele, Mahlubandilec; Pepeta, Lungilec,d; Mogashoa, Marye; Rivadeneira, Emilia D.f; Abrams, Elaine J.a,b,g

doi: 10.1097/QAD.0000000000002309
Research Letter
Buy

We report data from an observational cohort of South African children living with HIV less than 12 years of age eligible for fast track antiretroviral therapy (rapid) initiation. We found that less than half of children eligible for rapid antiretroviral therapy initiation based on immunologic and disease status started treatment within 1 week.

aICAP at Columbia

bDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA

cPort Elizabeth Hospital Complex

dNelson Mandela University, Faculty of Health Sciences, Port Elizabeth

eUS Centers for Disease Control and Prevention, Pretoria, South Africa

fUS Centers for Disease Control and Prevention, Atlanta, Georgia

gCollege of Physicians & Surgeons, Columbia University, New York, New York, USA.

Correspondence to Chloe A. Teasdale, ICAP-Columbia University, Mailman School of Public Health, Columbia University, 722 W168th Street, Room 1319, New York, NY 10032, USA. Tel: +1 212 304 7920; fax: +1 212 342 1824; e-mail: ct116@columbia.edu

Received 25 April, 2019

Revised 30 May, 2019

Accepted 6 June, 2019

Copyright © 2019 Wolters Kluwer Health, Inc.